Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06628570 · ClinicalTrials.gov registry record · NA
Screening Strategies Among High-risk Populations for Anal Cancer
A NA study of Neoplasms and HPV-Related Anal Squamous Cell Carcinoma, sponsored by Lisa Flowers.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 4
- Study locations
NCT06628570 is a NA study of Neoplasms and HPV-Related Anal Squamous Cell Carcinoma that is actively recruiting participants, run by Lisa Flowers. The registered enrollment target is 500 participants, below the 1,618-participant average among 158 other Neoplasms trials with a reported enrollment target (69% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT06628570, a NA study of Neoplasms and HPV-Related Anal Squamous Cell Carcinoma, is actively recruiting participants, sponsored by Lisa Flowers.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of the proposed research is to 1) examine the performance of emerging screening methods for anal high-grade squamous intraepithelial lesion (aHSIL), a precancerous condition of anal cancer, among populations at high risk for anal cancer and 2) characterize DNA methylation, immunologic response, and environmental factors associated with aHSIL.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST HRA + Biopsy
- DIAGNOSTIC_TEST Anal Cytology
- DIAGNOSTIC_TEST Genotyping of anal hrHPV infection
- DIAGNOSTIC_TEST CINtec®PLUS
Study Locations (4)
Florida
- University of Miami Miller School of Medicine-Sylvester Cancer Center - Miami
- University of Miami School of Medicine at Jackson Memorial Hospital (JMH) - Miami
Georgia
- Grady Memorial Hospital - Atlanta
- The Ponce Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2027-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06628570
The ClinicalTrials.gov registry entry for NCT06628570 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,618-participant average among 158 other Neoplasms trials with a reported enrollment target (69% lower). The listed sponsor is Lisa Flowers, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neoplasms appearing as the primary indexed condition, and to 4 interventions - of which HRA + Biopsy is the first listed.
NCT06628570 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT06628570 about?
NCT06628570 is a clinical study titled "Screening Strategies Among High-risk Populations for Anal Cancer". The goal of the proposed research is to 1) examine the performance of emerging screening methods for anal high-grade squamous intraepithelial lesion (aHSIL), a precancerous condition of anal cancer, among populations at high risk for anal cancer and 2) characterize DNA methylation, immunologic respo...
What is the current status of trial NCT06628570?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2024-12-16. Estimated completion is 2027-10.
What conditions does trial NCT06628570 study?
This clinical trial studies the following conditions: Neoplasms, HPV-Related Anal Squamous Cell Carcinoma.
What interventions are being tested in trial NCT06628570?
The interventions under investigation include: HRA + Biopsy (DIAGNOSTIC_TEST), Anal Cytology (DIAGNOSTIC_TEST), Genotyping of anal hrHPV infection (DIAGNOSTIC_TEST), CINtec®PLUS (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06628570?
This trial is sponsored by Lisa Flowers, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06628570 being conducted?
This trial has 4 study locations across Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
RECRUITING · NA
-
Biennial CEM in Women With a Personal History of Breast Cancer
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
-
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
RECRUITING · NA
-
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.